Skip to main content
MYGN logo
MYGN
(NASDAQ)
Myriad Genetics, Inc.
$4.32-- (--)
Loading... - Market loading

Myriad Genetics (MYGN) Stock Price & Financial Analysis

Myriad Genetics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$4.19 - $4.37
52-Week High$8.59
52-Week Low$3.53
Open$4.31
Volume1.13M
Average Volume (3M)1.93M
Market Cap400.96M
Shares Outstanding92.60M
Price to Sales (P/S)0.50
Price to Book (P/B)1.11
EV/EBITDA-0.97
Revenue (TTM)824.50M
Net Income (TTM)-365.90M
Free Cash Flow (TTM)-19.60M
EPS (TTM)$-3.95
Profit Margin-44.38%
Operating Margin6.69%
Return on Equity (ROE)-99.43%
Debt to Equity0.34
50-Day MA$4.45
200-Day MA$5.91
52-Week Change-10.62%
Annual Dividend$0.00
Dividend Yield0.00%
Last Dividend Ex-DateJul 1, 2009

Frequently Asked Questions About Myriad Genetics

What is the current stock price for MYGN?

As of the latest trading session, MYGN stock trades at $4.32. The 52-week range is $3.53–$8.59, with a day range of $4.19–$4.37.

What is the P/E ratio for MYGN?

The P/E ratio (Price-to-Earnings) for MYGN is shown in the Key Statistics section. This valuation metric helps compare Myriad Genetics, Inc. to industry peers.

Does MYGN pay dividends?

Myriad Genetics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for MYGN?

Analyst ratings and recommendations for MYGN are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of MYGN?

Myriad Genetics's market capitalization is $400.0M, classifying it as a small-cap company. Myriad Genetics operates in the Healthcare sector within the Diagnostics & Research industry.